MiaMed Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

MiaMed General Information

Description

Developer of brain disorder medicines. The company provides research and development services for cyclin-dependent kinase-like 5 focused on treatment of brain disorders.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 641 Lexington Avenue
  • 15th Floor
  • New York, NY 10022
  • United States
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 641 Lexington Avenue
  • 15th Floor
  • New York, NY 10022
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MiaMed Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MiaMed‘s full profile, request access.

Request a free trial

MiaMed FAQs

  • Where is MiaMed headquartered?

    MiaMed is headquartered in New York, NY.

  • What industry is MiaMed in?

    MiaMed’s primary industry is Buildings and Property.

  • Is MiaMed a private or public company?

    MiaMed is a Private company.

  • What is the current valuation of MiaMed?

    The current valuation of MiaMed is .

  • What is MiaMed’s current revenue?

    The current revenue for MiaMed is .

  • When was MiaMed acquired?

    MiaMed was acquired on 05-Jul-2016.

  • Who acquired MiaMed?

    MiaMed was acquired by Amicus Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process